WilmerHale Successfully Represents Mayne in its Acquisition by Hospira

• 1.18.2007

WilmerHale successfully represented its client Mayne Pharma Ltd. before the US Federal Trade Commission to secure antitrust clearance of Mayne's acquisition by Hospira, Inc. The transaction will make Hospira one of the world's leading generic injectable drug manufacturers. The January 18, 2007 clearance decision required no divestitures material to the transaction and came only two and a half months after the Commission initiated a Second Request investigation.

The WilmerHale antitrust lawyers working on the transaction included William Kolasky, Jeff Ayer, Andrew Ewalt, Laura Hill, Alexander Krulic, Elizabeth de Luca, Jeffrey Schomig, Deirdre Waters, and Dan Matheson.